Medications

First two-drug regimen approved for HIV-1 treatment

(HealthDay)—The U.S. Food and Drug Administration has announced the approval of Dovato (dolutegravir and lamivudine), the first approved two-drug, fixed-dose, complete regimen for adults with HIV-1 who have not been previously ...

Cardiology

Enlist a pharmacist to help manage high blood pressure

(HealthDay)—High blood pressure is one of the biggest risk factors for heart disease and stroke, yet has no symptoms of its own. That's why having your blood pressure checked regularly is a must, as is controlling it if ...

Health

Impact of complex medication regimen in elderly unclear

(HealthDay)—The association between medication regimen complexity and either treatment nonadherence or hospitalization in elderly patients remains unclear, according to a review published online Dec. 19 in the Journal of ...

Oncology & Cancer

More chemo drugs don't improve treatment of rare bone cancer

Osteosarcoma patients with tumors that haven't responded well to the standard chemotherapy regimen have unimproved outcomes and more side effects when given two additional drugs, a large international trial has found.

page 1 from 11